More than half of all adults in the U.S. are eligible for semaglutide (Ozempic, Wegovy, Rybelsus), researchers estimated.

Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...

X Biopharma Ltd. (SG:42C) has released an update. iX Biopharma Ltd. announced that its novel semaglutide sublingual wafer, iXB 401, achieved 20 ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new British ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Right now, insurance companies typically only cover the cost of semaglutide if a doctor indicates its use against type 2 ...

As millions patients struggled to fill their prescriptions for the new weight loss drugs, many have turned to compounded copies.

Since the discovery of statins and the Scandinavian Simvastatin Survival Study (4S) results three decades ago, remarkable advances have been made in the treatment of dyslipidaemia, a major risk factor ...

The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...

Two drugs targeting lipoprotein(a ... Other key studies included intensive blood pressure management in type 2 diabetes, as ...